申请人:Bayer Aktiengesellschaft
公开号:US04156729A1
公开(公告)日:1979-05-29
6-Substituted-1,2-benzisothiazolin-3-ones carrying an aminoalkyl group in the 2-position and being optionally substituted in the 4- and/or 5-position are antithrombotic agents. The compounds, of which 2-(2-diethylaminoethyl)-4,5-dimethyl-1,2-benzisothiazolin-3-one is a representative embodiment, can be prepared by cyclization of an appropriately substituted bis-[2-(aminoalkylcarbamyl)phenyl]disulfide, or by other disclosed methods.
携带在2-位的氨基烷基基团并在4-和/或5-位可选择地被取代的6-取代-1,2-苯并异噻唑啉-3-酮是抗血栓剂。这些化合物可以通过适当取代的双-[2-(氨基烷基氨基甲酰)苯基]二硫化物的环化或其他公开方法制备,其中2-(2-二乙基氨基乙基)-4,5-二甲基-1,2-苯并异噻唑啉-3-酮是一种代表性实施形式。